tPA Clot-Busting Drug – Greater Criticality for Stroke Symptoms in Women

During crisis scenarios of stroke symptoms in women arising, non-administration of tPA (tissue plasminogen activator) could have shoddier results in women as compared to men that were not given the drug. This was the finding of a new-fangled study that is printed in the March edition of Neurology journal.

During the course of the press release conference, Dr. Michael D. Hill, from the Univ. of Calgary, Canada, one of the authors of this study stated that stroke symptoms in women need urgent treatment. The authors observed that those females who did not receive the treatment suffered inferior quality of existence in comparison to those males subsequent to having suffered a stroke.

Dr. Hill and his associates did a data analysis on over two thousand stroke patients. From the 232 entrants that had undergone tPA treatment in 3 hours subsequent to stroke symptoms surfacing, forty-four percent of them were found to be in women.

Solely 58% of females that were not administered tPA were observed to have favourable results 6 months subsequent to having suffered from a stroke, in comparison to the seventy percent of males that were not administered the medication. tPA treatment was noted to have analogous results in both the genders.

Dr. Hill expounded about several reasons as to why females that were not administered treatment using the tPA clot-dissolving medication appeared to fare not as good as the males, inclusive of natural causes. Dr. Hill mentioned that as over thirty percent of females were widows in comparison to seven percent of the males during the instant the stroke occurred, hence they did not have a partner who might have otherwise donned the care giving role. Additionally, subsequent to a stroke, women were noted to be suffering from depression far more as compared to the males that is believed to slacken recuperation.

The American Heart Association (AHA) has strongly advised individuals in seeking prompt medical assistance in case it is believed that they have suffered a heart attack or stroke. The quicker tPA treatment is commenced, more improved is the likelihood of recuperation.

tPA is the sole medication that has garnered approval of the U.S. FDA ( Food and Drug Administration) for critical ischemic stroke treatment. A blood clot dissolver, tPA helps in resolving the key reason for majority of the stroke and heart attack cases that arise.

Research have shown that efficacy of tPA is optimal when administered in the initial 3 hours following the foremost signs surfacing. Administration of tPA is intricate and is done via intravenous route in the patient’s arm conducted by hospital staff.

Prompt administration of tPA could considerably lower the outcomes of stroke and reduces lasting disability. Though tPA could lower disability arising due to stroke or heart attack, however it additionally has been linked to greater chances of bleeding.

Popularity: 1% [?]